Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.

The Prostate - 1 May 2008

Tischkowitz Marc, Sabbaghian Nelly, Ray Anna M, Lange Ethan M, Foulkes William D, Cooney Kathleen A

Abstract excerpt

BACKGROUND: The genetic basis of susceptibility to prostate cancer (PRCA) remains elusive. Mutations in BRCA2 have been associated with increased prostate cancer risk and account for around 2% of young onset (<56 years) prostate cancer cases. PALB2 is a recently identified breast cancer susceptib...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Fanconi Anemia Complementation Group N Protein
Share to Fathers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Nuclear Proteins

Share to Prostatic Neoplasms

Share to Siblings

Share to Tumor Suppressor Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 18288683
DOI: 10.1002/pros.20729
PMCID: PMC2683627

Genes

PALB2
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18288683-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the gene coding for the BRCA2-interacting protein PALB2 in hereditary prostate cancer.PMID 18288683Read ↗

PALB2 mutations and prostate cancer risk and survival.Semantic proximity Read ↗

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.Semantic proximity Read ↗

Identification and Characterization of an Exonic Duplication in PALB2 in a Man with Synchronous Breast and Prostate Cancer.Semantic proximity Read ↗

PALB2 Variants: Protein Domains and Cancer Susceptibility.Semantic proximity Read ↗

A recurrent mutation in PALB2 in Finnish cancer families.Semantic proximity Read ↗

PALB2 variants in hereditary and unselected Finnish prostate cancer cases.Semantic proximity Read ↗

PALB2 and the risks for cancer: implications for clinical care.Semantic proximity Read ↗

Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer.Semantic proximity Read ↗

Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic CancerSemantic proximity Read ↗

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.Semantic proximity Read ↗

The role of the BRCA2 gene in susceptibility to prostate cancer revisited.Semantic proximity Read ↗

Genetic landscape of homologous recombination repair genes in early-onset/familial prostate cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.